VenatoRx Pharmaceuticals' Series A Round

VenatoRx Pharmaceuticals raised a round of funding on December 04, 2013.

VenatoRx Pharmaceuticals is a disease-focused pharmaceutical company dedicated to the discovery and development of novel anti-infective agents. The company's goal is to identify and progress into clin…

Articles about VenatoRx Pharmaceuticals' Series A Round: